The role of innate immunity in diabetic nephropathy and their therapeutic consequences.

Authors:
Yang M; Zhang C.

Journal:
J Pharm Anal

Publication Year: 2023

DOI:
10.1016/j.jpha.2023.09.003

PMCID:
PMC10859537

PMID:
38352948

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Pharm Anal

Abbreviation: J Pharm Anal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A chiral metal-organic framework {(HQA)(ZnCl<sub>2</sub>)(2.5H<sub>2</sub>O)}<sub>n</sub> for the e…
Zheng X; Zhang Q; Ma Q and 3 more (2023) - Transparency Score: 3/6
A proteomic landscape of pharmacologic perturbations for functional relevance.
Liu Z; Jiang S; Hao B and 8 more (2023) - Transparency Score: 3/6
A robust luminescent assay for screening alkyladenine DNA glycosylase inhibitors to overcome DNA re…
Song YQ; Li GD; Niu D and 5 more (2023) - Transparency Score: 3/6
Benzodiazepines in complex biological matrices: Recent updates on pretreatment and detection method…
Zhang YX; Zhang Y; Bian Y and 5 more (2023) - Transparency Score: 3/6
Biosensors for waterborne virus detection: Challenges and strategies.
Song X; Fredj Z; Zheng Y and 4 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"This work was financially supported by the 10.13039/501100001809National Natural Science Foundation of China (Grant Nos.: 82100801, 81974096, 81770711, 81974097, and 81961138007). Min Yang: Writing - Original draft preparation, Reviewing and Editing, Funding acquisition; Chun Zhang: Resources, Writing - Reviewing and Editing, Supervision, Funding acquisition."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025